Oral anticoagulant therapy in the chronic phase of myocardial infarction

Area of Science:

• Cardiology
• Thrombosis Research
• Pharmacology

Background:

• Coronary thrombosis is a known cause of myocardial infarction (heart attack).
• Heart attack survivors face increased risks of mortality and re-infarction compared to the general population.
• Thrombosis significantly contributes to this heightened risk in post-myocardial infarction patients.

Purpose of the Study:

• To review the efficacy of oral anticoagulants in secondary prophylaxis after acute myocardial infarction.
• To evaluate the controversial role of these drugs in preventing subsequent cardiac events in survivors.

Main Methods:

• Literature review of studies on oral anticoagulant use in secondary prevention of myocardial infarction.
• Analysis of data regarding mortality and morbidity in patients treated with anticoagulants post-heart attack.

Main Results:

• The role of oral anticoagulants in secondary prevention of myocardial infarction remains a subject of debate.
• Evidence suggests a potential benefit in reducing re-infarction and mortality, but risks must be considered.

Conclusions:

• Oral anticoagulants are a potential therapeutic option for secondary prevention in heart attack survivors.
• Further research and careful patient selection are necessary to optimize their use and manage risks.